GlaxoSmithKline board rejects ACDIMA’s takeover offer for Egypt assets
GlaxoSmithKline on Sunday said its board rejected a request from the Arab Company for Drug Industries & Medical…
Browsing Tag
Hikma Pharmaceuticals
Hikma, GlaxoSmithKline cease talks over potential deal to buy Egypt, Tunisia assets
GlaxoSmithKline said on Thursday that its majority shareholder Glaxo Group Limited and Hikma Pharmaceuticals have…
Rameda withdraws offer to acquire GlaxoSmithKline Egypt stake
Egypt’s Rameda Pharmaceutical said in a bourse filling on Tuesday it had withdrawn its proposal to acquire…
GlaxoSmithKline in talks with Hikma to sell Egypt stake, rules out talks with Rameda
GlaxoSmithKline will focus its efforts and resources on discussing the sale of its stake in Egypt with Hikma…
Rameda joins race to buy GlaxoSmithKline assets in Egypt
Egypt's Rameda Pharmaceutical said on Tuesday it had submitted a non-binding letter of intent to purchase…
GlaxoSmithKline allows Hikma Pharmaceuticals due diligence on Egypt, Tunisia assets
GlaxoSmithKline said on Wednesday its board of directors has allowed Hikma Pharmaceuticals, which is interested in…
Hikma mulls buying GlaxoSmithKline assets in Egypt and Tunisia
Hikma Pharmaceuticals announced on Tuesday plans to buy GlaxoSmithKline’s stake in some assets including the…
Egypt’s HC eyes completion of two more acquisitions before 2016-end
Egypt’s investment bank, HC Securities and Investment plans to make two acquisitions totalling 700 million Egyptian…
HC says has run $116.6 mln acquisition deals since early 2016
Egypt’s investment bank, HC Securities and Investment has managed acquisitions totalling 1.035 billion Egyptian…
